Haemodynamic effects of losartan an angiotensin II receptor antagonist in patients with cirrhosis and portal hypertension.

被引：0
|
作者：
Tripathi, D [1 ]
Therapondos, G [1 ]
Lui, HF [1 ]
Hayes, PC [1 ]
机构：
[1] Royal Edinburgh Infirm, Liver Unit, Edinburgh, Midlothian, Scotland
来源：
HEPATOLOGY | 2000年 / 32卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1470
引用
收藏
页码：527A / 527A
页数：1
相关论文
共 50 条
  • [1] Haemodynamic effects of chronic administration of Losartan, an angiotensin II receptor anatagonist, in patients with cirrhosis and portal hypertension
    Tripathi, D
    Therapondos, G
    Lui, HF
    Webb, DJ
    Hayes, PC
    JOURNAL OF HEPATOLOGY, 2002, 36 : 66 - 66
  • [2] Hemodynamic effects of the angiotensin II receptor antagonist candesartanchilexetil in rats with cirrhosis and portal hypertension.
    Scheller, I
    Laue, O
    Klanac, D
    Daudi, S
    Toex, U
    Goeser, T
    Steffen, HM
    HEPATOLOGY, 2002, 36 (04) : 720A - 720A
  • [3] Hemodynamic effects of the angiotensin II receptor antagonist irbesartan in patients with cirrhosis and portal hypertension
    Schepke, M
    Werner, E
    Biecker, E
    Schiedermaier, P
    Heller, J
    Neef, M
    Stoffel-Wagner, B
    Hofer, U
    Caselmann, WH
    Sauerbruch, T
    GASTROENTEROLOGY, 2001, 121 (02) : 389 - 395
  • [4] Effect of losartan, an angiotensin II receptor antagonist, on portal pressure in cirrhosis
    Schneider, AW
    Kalk, JF
    Klein, CP
    HEPATOLOGY, 1999, 29 (02) : 334 - 339
  • [5] Effect of losartan, an angiotensin II receptor antagonist, on portal pressure in liver cirrhosis
    Schneider, AW
    Rambach, W
    Kuhn, R
    Kalk, JF
    Klein, CP
    GUT, 1997, 41 : A233 - A233
  • [6] The angiotensin II receptor antagonist candesartan is not effective in reducing portal hypertension in patients with cirrhosis
    Heim, Markus H.
    Jacob, Ludwig
    Beglinger, Christoph
    DIGESTION, 2007, 75 (2-3) : 122 - 123
  • [7] Effect of losartan, an angiotensin II receptor antagonist, on portal pressure in liver cirrhosis.
    Schneider, AW
    Kalk, JF
    Klein, CP
    HEPATOLOGY, 1998, 28 (04) : 510A - 510A
  • [8] The development of COZAAR(R) (losartan potassium), the first angiotensin II receptor antagonist for hypertension.
    Goldberg, MR
    Eydelloth, RS
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1997, 213 : 150 - MEDI
  • [9] Chronic administration of losartan, an angiotensin II receptor antagonist, is not effective in reducing portal pressure in patients with preascitic cirrhosis
    Tripathi, D
    Therapondos, G
    Lui, HF
    Johnston, N
    Webb, DJ
    Hayes, PC
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (02): : 390 - 394
  • [10] Clinical usefulness of the angiotensin II receptor antagonist losartan in patients with portal hypertensive gastropathy
    Wagatsuma, Y
    Naritaka, Y
    Shimakawa, T
    Kanako, H
    Keiichiro, I
    Shunichi, S
    Konno, S
    Katsube, T
    Ogawa, K
    HEPATO-GASTROENTEROLOGY, 2006, 53 (68) : 171 - 174
12345